[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:secondary-hyperparathyroidism":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":34,"states":39},"Secondary Hyperparathyroidism",4,[7,15,22,28],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT03633708","A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis",[11],"Phase 3","RECRUITING","2026-08-26T02:18:45.196599Z","2026-05-05T02:35:31.671902Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07494045","Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants",[19],"Phase 2","2026-08-26T02:18:46.137046Z","2026-05-05T02:43:27.622465Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT05997810","Parathyroid Tumor Clonal Status",[],"2026-08-26T02:16:07.529922Z","2026-05-13T02:55:06.400101Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT05880914","Precision Medicine Approaches to Renal Osteodystrophy",[],"2026-08-26T02:15:43.339060Z","2026-05-13T02:55:06.391407Z",[35],{"biomarker":36,"count":37,"slug":38},"Parathyroid Hormone",3,"parathyroid-hormone",[40],{"state":41,"count":5,"slug":42},"Missouri","missouri"]